Evidence map›Paper›PMID 30410518›Full record

ArticleInterventional neurology2018

Direct Thrombectomy versus Bridging for Patients with Emergent Large-Vessel Occlusions.

Ronen R Leker, Jose E Cohen, David Tanne, David Orion, Gregory Telman, Guy Raphaeli, Jacob Amsalem, Jonathan Y Streifler, Hen Hallevi, Pavel Gavriliuc and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Interventional neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 3 pooled it
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Ronen R LekerDepartment of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Jose E CohenDepartment of Neurosurgery, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
David TanneChaim Sheba Medical Center, Tel-Hashomer, Israel.
David OrionChaim Sheba Medical Center, Tel-Hashomer, Israel.
Gregory TelmanRambam Medical Center, Haifa, Israel.
Guy RaphaeliRabin Medical Center, Petach Tikva, Israel.
Jacob AmsalemRambam Medical Center, Haifa, Israel.
Jonathan Y StreiflerRabin Medical Center, Petach Tikva, Israel.
Hen HalleviTel-Aviv Sourasky Medical Center, Tel Aviv, Israel.
Pavel GavriliucDepartment of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Natan M BornsteinTel-Aviv Sourasky Medical Center, Tel Aviv, Israel.
Anat HorevSoroka Medical Center, Beer Sheva, Israel.
Nour Eddine YaghmourDepartment of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Hadassah Medical Center · ILRabin Medical Center · ILRambam Health Care Campus · ILSheba Medical Center · ILTel Aviv Sourasky Medical Center · ILSoroka Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsPatients with emergent large-vessel occlusion (ELVO) that present earlier than 4 h from onset are usually treated with bridging systemic thrombolysis followed by endovascular thrombectomy (EVT). Whether direct EVT (dEVT) could improve the chances of favorable outcome remains unknown.

methodsConsecutively, prospectively enrolled patients with ELVO presenting within 4 h of onset were entered into a National Acute Stroke Registry of patients undergoing revascularization. Patients treated with bridging were compared to those treated with dEVT. Excellent outcome was defined as having a modified Rankin Scale score ≤1 at 90 days following stroke.

resultsOut of 392 patients that underwent thrombectomy, 270 (68%) presented within 4 h and were included. Of those, 159 (59%) underwent bridging and 111 (41%) underwent dEVT. Atrial fibrillation and congestive heart failure were more common in the dEVT group (43 vs. 30%,

conclusionsThe chances of attaining excellent functional outcomes are similar in ELVO patients undergoing dEVT or bridging.

Indexed as

Endovascular treatmentReperfusionStentrieverStrokeThrombolysis

Identifiers

PMID30410518
PMCPMC6216721
OpenAlexW2811179595

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.